Conference Faculty



Welcome to

9th Annual

Cardiovascular Disease Update

October 27, 2015

Evaluation and CME Credit Certificate

The conference evaluation and CME credit certificate are available via the Internet. Once you have completed the evaluation and claimed credit commensurate with your participation in this activity a printable certificate of credit will be available.

• Please go to the link to the evaluation and certificate. You will also be emailed this link following the conference.

• At the end of the evaluation you will be automatically forwarded to the credit claim screen. If you have already registered with the Case Western Reserve University CME website, please log in using your email address and password.  If you have never logged into the Case Western Reserve University CME website before, enter your email address, select the “I am a new user” radio button and follow the prompts. You must set up a profile before you can enter the CME code.

• Enter CME Code 170870.

• You will be asked enter the credits commensurate with your participation in the activity. Once you’ve entered those credits a certificate will come up that you can print for your records.

Physicians: Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Case Western Reserve University School of Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses & Physician Assistants: The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept AMA PRA Category 1 CreditsTM toward recertification requirements.

For Further Information

Contact the CME Program

10524 Euclid Avenue

Cleveland, OH 44106-6026

Tel: (216) 983-1239 Fax: (216) 844-8133

Email: medcme@case.edu



Program Agenda

5:00-6:00pm Registration and reception

6:00-6:10 Introduction and Welcome

Daniel Simon, MD

6:10-6:35 Heart Failure: Who is Refractory and When Should I Refer for Advanced Therapies?

Michael Zacharias, DO

6:35-7:00 Cardiovascular Risk Prediction: Risk Scores and Beyond

Daniel Simon, MD

7:00-7:30 Mini Debate: MitraClip vs. Surgical Mitral Valve Repair for High Risk Patients with Mitral Regurgitation

Guilherme Attizzani, MD and Benjamin Medalion, MD

7:30-7:55 AAA: Open Surgical Repair or EVAR?

Vikram Kashyap, MD

7:55-8:05 Break

8:05-9:00 Clinical Case Discussion

Moderator: Sri Krishna Madan Mohan, MD

Panelists: Teresa Carman, MD; Barry Effron, MD; Naim Farhat, MD; Atul Hulyalkar, MD; Judith Mackall, MD; Gregory Stefano, MD; William Wolf, MD; Todd Zeiger, MD; Christine Zirafi, MD

9:00-9:15 Closing Remarks

Daniel Simon, MD

Conference Faculty

Guilherme Attizzani, MD

Associate Director, Cardiovascular Imaging Core Laboratory

UH Case Medical Center

Assistant Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Attizzani reports no financial relationship with a commercial interest relevant to this activity. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Teresa Carman, MD

Director, Vascular Medicine

Medical Director, Center for Wound Care

UH Case Medical Center

Medical Director, Anticoagulation Monitoring Service

UH Harrington Heart & Vascular Institute

Assistant Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Carman has received research funding from Portola Pharmaceuticals and Tactile Inc., and the CME Program has determined there is no conflict of interest. Contribution will include discussion of unlabeled/investigational uses of a commercial product.

Barry Effron, MD

Director, Evaluation & Prevention Center

UH Harrington Heart & Vascular Institute

Figgie Family Chair in Clinical Cardiovascular Excellence

UH Case Medical Center

Associate Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Effron has received honoraria for speaking/teaching from Amgen and Boehringer-Ingelheim, and the CME Program has determined there is no conflict of interest.

Naim Farhat, MD

Medical Director, Harrington Heart & Vascular Institute at UH Elyria Medical Center

Clinical Associate Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Farhat reports no financial relationship with a commercial interest relevant to this activity.

Atul Hulyalkar, MD

Medical Director, Harrington Heart & Vascular Institute at St. John Medical Center

Assistant Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Hulyalkar reports no financial relationship with a commercial interest relevant to this activity.

Vikram Kashyap, MD

Co-Chair, Clinical Executive Committee

UH Harrington Heart & Vascular Institute

Chief, Division of Vascular Surgery and Endovascular Therapy

UH Case Medical Center

Professor of Surgery

Case Western Reserve University School of Medicine

Dr. Kashyap reports no financial relationship with a commercial interest relevant to this activity. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Judith Mackall, MD

Chief Community Officer – Eastern Region

UH Harrington Heart & Vascular Institute

Spitz Master Clinician

Director, Electrophysiology Fellowship Program

UH Case Medical Center

Associate Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Mackall has received honoraria from St. Jude Medical, and the CME Program has determined there is no conflict of interest.

Benjamin Medalion

Department of Surgery

UH Case Medical Center

Clinical Associate Professor of Surgery

Case Western Reserve University School of Medicine

Dr. Medalion reports no financial relationship with a commercial interest relevant to this activity. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Sri Krishna Madan Mohan, MD

Chief Quality Officer

UH Harrington Heart & Vascular Institute

Assistant Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Mohan reports no financial relationship with a commercial interest relevant to this activity.

Daniel Simon, MD

Course Director

President, UH Harrington Heart & Vascular Institute

Chief, Division of Cardiovascular Medicine

UH Case Medical Center

Herman K. Hellerstein Chair in Cardiovascular Research

Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Simon has received honoraria and grant support from Medtronic, honoraria from HeartFlow and is owner/founder and maintains intellectual property rights in Sujana Biotech, and the CME Program has determined there is no conflict of interest.

Gregory Stefano, MD

Medical Director, Harrington Heart & Vascular Institute at UH Geauga Medical Center

Assistant Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Stefano reports no financial interest with a commercial interest relevant to this activity.

William Wolf, MD

Medical Director, Harrington Heart & Vascular Institute at UH Ahuja Medical Center

Assistant Clinical Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Wolf has received honoraria for speaking from AstraZeneca, and the CME Program has determined there is no conflict of interest.

Michael Zacharias, DO

Division of Cardiovascular Medicine

Harrington Heart & Vascular Institute

UH Case Medical Center

Assistant Professor of Medicine

Case Western Reserve University School of Medicine

Dr. Zacharias reports no financial relationship with a commercial interest relevant to this activity.

Todd Zeiger, MD

Vice President

UH Primary Care Institute

Dr. Zeiger reports no financial relationship with a commercial interest relevant to this activity.

Christine Zirafi, MD

Director, women’s Cardiovascular Center

Harrington Heart & Vascular Institute

Medical Director, UH Harrington Heart & Vascular Institute at UH Parma Medical Center

Dr. Zirafi reports no financial relationship with a commercial interest relevant to this activity.

Planning Committee

Daniel Simon, MD

Course Director

Dr. Simon has received honoraria and grant support from Medtronic, honoraria from HeartFlow and is owner/founder and maintains intellectual property rights in Sujana Biotech, and the CME Program has determined there is no conflict of interest.

Barry Effron, MD

Dr. Effron has received honoraria for speaking/teaching from Amgen and Boehringer-Ingelheim, and the CME Program has determined there is no conflict of interest.

Disclosure Policy

The policy of Case Western Reserve University School of Medicine CME Program requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the education activity) disclose to the activity participants all relevant financial relationships with commercial interests. Disclosure will be made to activity participants prior to the commencement of the activity. Case Western Reserve University School of Medicine also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of pharmaceutical products or medical devices.

Learning Objectives

After attending this program, participants will be able to:

• Describe advanced therapies such as cardiac resynchronization therapy and mechanical circulatory assistance for refractory heart failure patients

• Explain the importance of risk assessment with respect to new lipid guidelines and primary prevention

• Identify the risks and benefits of mitral valve replacement vs. repair

• Define the indications for open surgical repair vs. EVAR

• Discuss the latest diagnostics and treatment strategies for patients with DVT/PE, AF, CAD and PAD

Medical Disclaimer

Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.

Although every effort is made to ensure that this material is accurate and up-to-date, it is provided for the convenience of the user and should not be considered definitive. Since medicine is an ever-changing science, neither the authors nor Case Western Reserve School of Medicine nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information.

Readers are encouraged to confirm the information contained herein with other sources. This information should not be construed as personal medical advice and is not intended to replace medical advice offered by physicians. Case Western Reserve University School of Medicine will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising therefrom.

Acknowledgments

Funding from our industry partners is gratefully acknowledged

Grants

Thoratec

Exhibitors

Abbott Vascular ♦ Abiomed ♦ Amgen ♦ AstraZeneca

Bayer ♦ Boston Scientific ♦ Bristol-Myers Squibb

Daiichi-Sankyo ♦ eNNOVEA Medical ♦ Genzyme ♦ Gilead

HeartWare Inc. ♦ Janssen ♦ Lantheus ♦ Lilly, USA

Medtronic ♦ Merck & Co., Inc. ♦ Novartis

Otsuka ♦ Pfizer ♦ Regeneron

St. Jude Medical ♦ The Medicines Company

Acceptance of funding in support of this program does not constitute endorsement of any product or manufacturer.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download